Page results
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
-
UCLH continues to achieve excellent results in the National Inpatient Survey. In 2021 patients rated their overall care as 8.5 out of 10 which is the top score in London and the second best in the Shelford Group.
-
The Royal Parks Half Marathon makes a spectacular return this weekend.
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
More than 800 patients on waiting lists for Ear, Nose and Throat appointments across North Central London seen in two days during ENT surgery ‘super-weekend’
File results
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports